Companies: 10,795·Total market cap: $144.5T
Pluri Inc.

Pluri Inc.

PLURNASDAQHealthcare● Active
$2.32
+$0.01(+0.43%)
Market Cap$20860665
P/E Ratio
52W High$5.96
52W Low$2.22

Pluri Inc. (PLUR) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

plur · pe ratio · data through Jun 30, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Pluri Inc. (PLUR) measures how much investors pay for each dollar of the company's trailing earnings. PLUR's current PE ratio of N/A is calculated by dividing its stock price of $2.32 by its TTM earnings per share of -$2.60.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-06-30

Forward P/E
N/A
FY2026 est. EPS $-2.70
Based on 1 analyst
EPS (TTM)
-$2.60
TTM · diluted EPS
PEG Ratio
-0.03
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Pluri Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2006 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Pluri Inc.
Pluri Inc.You
PLUR
$21MN/A-$2.60
AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc.
ANTX
$105MN/A-$1.16
Boundless Bio, Inc.
Boundless Bio, Inc.
BOLD
$32MN/A-$2.60
iBio, Inc.
iBio, Inc.
IBIO
$28MN/A-$1.75
Intensity Therapeutics, Inc.
Intensity Therapeutics, Inc.
INTS
$7MN/A-$0.86
Iterum Therapeutics plc
Iterum Therapeutics plc
ITRM
$2MN/A-$1.26
Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc.
JSPR
$7MN/A-$3.95

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 20 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-06-30Latest
FY2025
$-3.56
2024-06-30
FY2024
$-3.99
2023-06-30
FY2023
$-6.18
2022-06-30
FY2022
$-10.25
2021-06-30
FY2021
$-14.19
2020-06-30
FY2020
$-12.81
2019-06-30
FY2019
$-22.90
2018-06-30
FY2018
$-19.75
2017-06-30
FY2017
$-25.45
2016-06-30
FY2016
$-23.38

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Pluri Inc. (PLUR) measures how much investors pay for each dollar of the company's trailing earnings. PLUR's current PE ratio of N/A is calculated by dividing its stock price of $2.32 by its TTM earnings per share of -$2.60.

PE Ratio = Stock Price ÷ EPS (TTM)
= $2.32 ÷ -$2.60 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

PLUR pe ratio · 6 questions

PLUR's current PE ratio is N/A as of 2026-06-09, based on a stock price of $2.32 and TTM EPS of -$2.60. Data sourced from Financial Modeling Prep via PLUR's SEC 10-K and 10-Q filings.

PLUR PE ratioWhat is PLUR PE ratioCurrent PE ratio of PLURPLUR PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Pluri Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09